Adjuvant postoperative radiation therapy for colonic carcinoma

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Colonic carcinoma (colon cancer) presents significant challenges in achieving local control and preventing recurrence.
• Adjuvant therapies are crucial for improving outcomes in patients with resected, advanced-stage colon cancer.

Purpose of the Study:

• To evaluate the efficacy of adjuvant postoperative radiotherapy in patients with Stage B2, B3, and C colonic carcinoma.
• To assess the impact of radiotherapy on local control and disease-free survival rates compared to surgery alone.

Main Methods:

• A cohort of 133 patients with Stage B2, B3, and C colonic carcinoma underwent resection for curative intent.
• Patients received adjuvant postoperative radiotherapy to the tumor bed.
• Outcomes were compared with a historic control series treated with surgery alone.

Main Results:

• Five-year actuarial local control and disease-free survival rates were 82% and 61%, respectively.
• Postoperative radiotherapy significantly reduced local regional failure compared to surgery alone.
• Local recurrence rates for Stage B3, C2, and C3 tumors were 8%, 21%, and 31% with radiotherapy versus 31%, 36%, and 53% with surgery alone.
• Disease-free survival improved by 13% and 12% for Stage B3 and C3 lesions, respectively, with radiotherapy.

Conclusions:

• Adjuvant postoperative radiotherapy is a promising treatment for Stage B3, C2, and C3 colonic carcinoma.
• Radiotherapy enhances local control and disease-free survival, particularly in advanced stages of colon cancer.
• Further investigation into this treatment approach is warranted.